Clinical efficacy of large dosage of liyuan pure lysothrombusase in the treatment of acute cerebral infarct

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2002, Vol. 7 ›› Issue (4): 353-354.

Previous Articles Next Articles

Clinical efficacy of large dosage of liyuan pure lysothrombusase in the treatment of acute cerebral infarct

WU Yun-Xia, ZHAO Min¹, ZHANG Qing-Chun², ZHAO Yun³

Medical Department, Second People' s Hospital of Suiping County, Suiping, Henan 463100;
¹Medical Department, Hospital of the Committee of the Plan of Birth of Suiping County, Suiping, Henan 463100;
²Second Medical Department, First People' s Hospital of Suiping county, Suiping, Henan 463100;
³the Third Medical Department, People' s Hospital of Xiping County, Xiping, Henan 463900

Received:2002-03-04 Revised:2002-06-28 Online:2002-08-26 Published:2020-11-24

Abstract

CLC Number:

R743.33

WU Yun-Xia, ZHAO Min, ZHANG Qing-Chun, ZHAO Yun. Clinical efficacy of large dosage of liyuan pure lysothrombusase in the treatment of acute cerebral infarct[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(4): 353-354.

[1]	WU Zhiyong, LIU Bingrong, LI Bin, TANG Rui. Value of red blood cell distribution width in predicting early poor neurologic improvement after intravenous thrombolysis in patients with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 307-314.
[2]	ZENG Xiaofan, XU Yiqi, LIU Shu, WU Qian, LI Zibao, HE Junjun, JIN Yuelong, ZHAO Yongli, HE Chunling, GAO Jialin. Retrospectively analysis of the effect of low-dose aspirin on primary prevention of non-fatal myocardial infarction and cerebral infarction in patients with type 2 diabetes mellitus [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 665-671.
[3]	SHI Can, CHEN Rong, CHEN Pengzi, WU Tian. Discussion of the necessity of placing vena cava filter in systemic thrombolytic therapy for patients with acute deep vein thrombosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1413-1418.
[4]	XU Honglei, XU Bingxin, ZU Qing, ZHAO Yan, GAO Pengfei, YU Yang. Effects of CYP2C19 gene polymorphism on the clinical prognosis of clopidogrel in elderly patients with acute cerebral infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1014-1020.
[5]	QIN Wenjie, YANG Zhiling, CAO Ailin, GAO Hang, JIANG Xianrui, SHEN Yue, QIAN Jiao. Advances in the study of new oral anticoagulants in cancer-associated venous thromboembolism [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 823-828.
[6]	ZHENG Qiluan, SHEN Qi, YU Jincong, YUAN Yao, CHEN Bo. Effects of rivaroxaban combined with Xuesaitong injection on deep venous thrombosis of lower extremity after spinal trauma surgery [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 337-341.
[7]	XIE Yuewu, ZHANG Fang, GUO Yan. Correlation between cerebral blood flow and infarct volume of the middle cerebral artery occlusion in mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 501-506.
[8]	WANG Meihua, WENG Qiuyan, ZHA Qin, NIU Yanfang. Effect of Xuesaitong soft capsule on acute lacunar cerebral infarction combined with cerebral microbleeds [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 574-579.
[9]	LI Lin, HUANG Ji-han, ZHANG Guang-min, LIU Chuan-gui, ZHANG Ping, XIE Xue-feng, HUANG Xiao-hui. Effects and safety of Xinmaining for cerebral infarction treatment:a systematic review [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1025-1032.
[10]	JI Na, ZHANG Gen-bao, HUANG Lu, WANG Fei, ZHANG Ya, WU Juan. Effects of platelet inhibitor from Agkistrodon halys venom on artery thrombosis in rabbit [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 987-990.
[11]	MA Ling-song, CHU Zhao-hu, ZHAO Shou-cai. Effect of Dengzhan shengmai capsules on the secondary prevention of atherosclerotis cerebral infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 442-445.
[12]	YAN Tao, ZHOU Qi-xin, FEI Hui-zhi, HU Xiao-ya, YANG Qiu-jun. A Meta-analysis for hemorrheologic parameters in patients with cerebral infarction or high risk population treated by Shuxuetong or Danshen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 302-307.
[13]	HUANG Lu, ZHANG Gen-bao, MIN Zhi-xue, MA Kai-ran, ZHENG Ru-qi, SUN Yao, WU Juan. Effect and mechanism of platelet inhibitor from Agkistrodon halys venom on artery thrombosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(12): 1355-1360.
[14]	CHENG Ye-dong. Clinical analysis on 80 patients with large area cerebral infarction of secondary temperature increased and recent prognosis relationship [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 325-327.
[15]	ZHANG Liu-fu, ZHU You-ling, WANG Guo-hong. Association study between plasma lipid, carotid artherosclerosis and acute stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(9): 1056-1059.

Clinical efficacy of large dosage of liyuan pure lysothrombusase in the treatment of acute cerebral infarct

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments